세계의 핵산 분리 및 정제 시장 :제품, 방법, 유형, 용도, 최종 사용자별 예측(2025-2030년)

The Nucleic Acid Isolation & Purification Market was valued at USD 6.94 billion in 2023, expected to reach USD 7.58 billion in 2024, and is projected to grow at a CAGR of 9.59%, to USD 13.18 billion by 2030.

Nucleic Acid Isolation and Purification (NAIP) is a crucial process in molecular biology, facilitating the extraction of DNA, RNA, or plasmid for a variety of applications. The necessity of NAIP lies in its foundational role for genetic testing, research, clinical diagnostics, biotechnology, and pharmaceutical applications. This market serves end-use segments such as academic institutions, diagnostic laboratories, hospitals, and biotech firms, underpinning crucial activities like sequencing, cloning, and analysis. Key factors influencing market growth include the rise in genetic disorder research, increased biopharmaceutical production, and technological advancements offering faster, more efficient isolation processes. An opportunity resides in the development of automated systems that reduce human error and expedite processes. Additionally, the expanding fields of personalized medicine and genomics provide fertile ground for market expansion, with a rising demand for rapid and high-throughput solutions. However, limitations include the regulatory landscape's complexity, which can delay product development and market entry, alongside cost constraints and technical challenges in achieving high-purity yield. Companies innovating in automated, next-generation isolation kits, focusing on user-friendly interfaces, and integrating bioinformatics are poised to capitalize on these opportunities. There is significant potential in enhancing sample quality and yield through novel reagent formulations and protocols, as well as investing in software that aids precise, consistent analysis of purification outcomes. The nature of this market is competitive and rapidly evolving, driven by technological innovation and a strong emphasis on precision and efficiency. Strategic collaborations, investment in R&D, and the adoption of scalable, cost-effective technologies are critical recommendations for businesses aiming to capture value in this sector. Investing in emerging markets and addressing the demand for minimally invasive methods could further strengthen the business outlook and contribute to sustainable growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Nucleic Acid Isolation & Purification Market

The Nucleic Acid Isolation & Purification Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising demand of pure nucleic acids in pharmaceutical and biotechnological industries
  • Favorable government guidelines and regulations for DNA extraction process
  • Increasing funding in genetic engineering, life science research, and forensics
• Market Restraints
  • High cost of set-up for nucleic acid isolation & purification
• Market Opportunities
  • Emerging innovations in nucleic acid extraction and purification techniques
  • Potential developments to extract DNA from plant and animal cells
• Market Challenges
  • Lack of subject matter expertise in the field of nucleic acid

Porter's Five Forces: A Strategic Tool for Navigating the Nucleic Acid Isolation & Purification Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Nucleic Acid Isolation & Purification Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Nucleic Acid Isolation & Purification Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Nucleic Acid Isolation & Purification Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Nucleic Acid Isolation & Purification Market

A detailed market share analysis in the Nucleic Acid Isolation & Purification Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Nucleic Acid Isolation & Purification Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Nucleic Acid Isolation & Purification Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Nucleic Acid Isolation & Purification Market

A strategic analysis of the Nucleic Acid Isolation & Purification Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Nucleic Acid Isolation & Purification Market, highlighting leading vendors and their innovative profiles. These include A&A Biotechnology, Abcam PLC, ABNova Corporation, Agilent Technologies Inc., Analytik Jena GmbH+Co. KG, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biomatik Corporation, Bioneer Corporation, Danaher Corporation, F. Hoffmann-La Roche Ltd., Genaxxon bioscience GmbH, Geneaid Biotech Ltd., GeneProof a.s, Genscript Biotech, Hamilton Company, HiMedia Laboratories Private Limited, Illumina Inc., MACHEREY-NAGEL GmbH & Co. KG, Merck KGaA, MP Biomedicals, New England Biolabs, Inc., Norgen Biotec Corp., NZYTech, Omega Bio-tek, Inc., Perkin Elmer Inc., Promega Corporation, Takara Bio Inc., Thermo Fisher Scientific Inc., and Zymo Research Corporation.

Market Segmentation & Coverage

This research report categorizes the Nucleic Acid Isolation & Purification Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Instruments, Kits, and Reagents.
• Based on Method, market is studied across Column-Based Isolation & Purification, Magnetic Bead-Based Isolation & Purification, and Reagent-Based Isolation & Purification.
• Based on Type, market is studied across Circulating Nucleic Acid Isolation & Purification, Genomic DNA Isolation & Purification, Messenger RNA Isolation & Purification, Micro RNA Isolation & Purification, PCR Cleanup, Plasmid DNA Isolation & Purification, and Total RNA Isolation & Purification.
• Based on Application, market is studied across Agriculture & Animal Research, Diagnostics, Drug Discovery & Development, and Personalized Medicine.
• Based on End User, market is studied across Academic & Government Research Institutes, Contract Research Organizations, Hospitals & Diagnostic Centers, and Pharmaceutical & Biotechnology Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising demand of pure nucleic acids in pharmaceutical and biotechnological industries
    • 5.1.1.2. Favorable government guidelines and regulations for DNA extraction process
    • 5.1.1.3. Increasing funding in genetic engineering, life science research, and forensics
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of set-up for nucleic acid isolation & purification
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging innovations in nucleic acid extraction and purification techniques
    • 5.1.3.2. Potential developments to extract DNA from plant and animal cells
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of subject matter expertise in the field of nucleic acid
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Growing demand for automation instruments to reduce the time for routine tasks
  • 5.2.2. Method: Significant adoption of column-based isolation & purification owing to scalability, allowing effective purification and isolation irrespective of the sample size

5.2.3. Type:

• 5.2.4. Application: Wider application of nucleic acid isolation & purification in diagnostics to provide guidance on therapy
• 5.2.5. End User: Growing usage of nucleic acid isolation & purification by the CROs for reliable results, and fast turnaround time
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Nucleic Acid Isolation & Purification Market, by Product

• 6.1. Introduction
• 6.2. Instruments
• 6.3. Kits
• 6.4. Reagents

7. Nucleic Acid Isolation & Purification Market, by Method

• 7.1. Introduction
• 7.2. Column-Based Isolation & Purification
• 7.3. Magnetic Bead-Based Isolation & Purification
• 7.4. Reagent-Based Isolation & Purification

8. Nucleic Acid Isolation & Purification Market, by Type

• 8.1. Introduction
• 8.2. Circulating Nucleic Acid Isolation & Purification
• 8.3. Genomic DNA Isolation & Purification
• 8.4. Messenger RNA Isolation & Purification
• 8.5. Micro RNA Isolation & Purification
• 8.6. PCR Cleanup
• 8.7. Plasmid DNA Isolation & Purification
• 8.8. Total RNA Isolation & Purification

9. Nucleic Acid Isolation & Purification Market, by Application

• 9.1. Introduction
• 9.2. Agriculture & Animal Research
• 9.3. Diagnostics
• 9.4. Drug Discovery & Development
• 9.5. Personalized Medicine

10. Nucleic Acid Isolation & Purification Market, by End User

• 10.1. Introduction
• 10.2. Academic & Government Research Institutes
• 10.3. Contract Research Organizations
• 10.4. Hospitals & Diagnostic Centers
• 10.5. Pharmaceutical & Biotechnology Companies

11. Americas Nucleic Acid Isolation & Purification Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Nucleic Acid Isolation & Purification Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Nucleic Acid Isolation & Purification Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. BioEcho Launches EchoLUTION FFPE DNA Kit for a Simplified DNA Extraction from FFPE Samples
  • 14.3.2. Invitek Molecular acquired by ALS Limited
  • 14.3.3. Bionano Genomics to Acquire Purigen Biosystems to Enable Further Simplified and Accelerated DNA Isolation for Optical Genome Mapping (OGM) and Address Difficult Sample Types in New Applications with Isotachophoresis (ITP) on the Ionic Purification System
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. A&A Biotechnology
• 2. Abcam PLC
• 3. ABNova Corporation
• 4. Agilent Technologies Inc.
• 5. Analytik Jena GmbH+Co. KG
• 6. Becton, Dickinson and Company
• 7. Bio-Rad Laboratories, Inc.
• 8. Biomatik Corporation
• 9. Bioneer Corporation
• 10. Danaher Corporation
• 11. F. Hoffmann-La Roche Ltd.
• 12. Genaxxon bioscience GmbH
• 13. Geneaid Biotech Ltd.
• 14. GeneProof a.s
• 15. Genscript Biotech
• 16. Hamilton Company
• 17. HiMedia Laboratories Private Limited
• 18. Illumina Inc.
• 19. MACHEREY-NAGEL GmbH & Co. KG
• 20. Merck KGaA
• 21. MP Biomedicals
• 22. New England Biolabs, Inc.
• 23. Norgen Biotec Corp.
• 24. NZYTech
• 25. Omega Bio-tek, Inc.
• 26. Perkin Elmer Inc.
• 27. Promega Corporation
• 28. Takara Bio Inc.
• 29. Thermo Fisher Scientific Inc.
• 30. Zymo Research Corporation